Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Science Consulting in Diabetes GmbH is an active German consulting and research services firm focused on diabetes technology, insulin pharmacology, and related scientific areas. The company is led by Professor Lutz Heinemann, an expert with decades of experience in diabetes research and technology assessment. The firm provides scientific advice to pharmaceutical companies and diagnostics firms as well as participating on advisory boards for major industry players. It does not develop its own drugs or devices but contributes to the field through consulting, research collaborations, publications, and participation in EU-funded projects such as AP@home.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Science Consulting in Diabetes.